The EPISODE II trial of cognitive and family therapy for relapse prevention in early psychosis: Rationale and sample characteristics

Journal of Mental Health

Volumn 17, Issue 1, 2008, Pages 19-32

  Gleeson, John ^a   Wade, Darryl ^a   Castle, David ^a   Gee, Donna ^b   Crisp, Kingsley ^b   Pearce, Tracey ^b   Newman, Belinda ^a   Cotton, Sue ^a   Alvarez Jimenez, Mario ^c   Gilbert, Monica ^d   McGorry, Patrick ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b THE NATIONAL CENTRE OF EXCELLENCE IN YOUTH MENTAL HEALTH   (Australia)

^c HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^d School of Medicine University of Cantabria ^*

Author keywords

CBT; First episode psychosis; Relapse prevention; Remission

Indexed keywords

ADULT; ANXIETY; ARTICLE; CLINICAL ASSESSMENT; COGNITIVE THERAPY; EARLY DIAGNOSIS; FAMILY STRESS; FAMILY THERAPY; FEMALE; FUNCTIONAL STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PSYCHOSIS; PSYCHOSOCIAL CARE; RECURRENCE RISK; RELAPSE; REMISSION; SUBSTANCE ABUSE;

EID: 39049085382     PISSN: 09638237     EISSN: 13600567     Source Type: Journal    
DOI: 10.1080/09638230701504999     Document Type: Article

References (64)

1. Addington, J., & Burnett, P. (2004). Working with families in the early stages of psychosis. In J. F. Gleeson, & P. D. McGorry (Eds.), Psychological interventions in early psychosis: A treatment handbook (pp. 99 - 116), Chichester: Wiley.
2. Addington, J., McCleery, A., & Addington, D. (2005). Three-year outcome of family work in an early psychosis program. Schizophrenia Research, 79, 107-116.
3. Almond, S., Knapp, M., Francois, C., Toumi, M., & Brugha, T. (2004). Relapse in schizophrenia: Costs, clinical outcomes and quality of life. British Journal of Psychiatry, 184, 346-351.
4. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders, 4th ed., Washington, DC: American Psychiatric Association.
5. Andreasen, N. C. (1984). Scale for Assessment of Negative Symptoms (SANS). Iowa City: University of Iowa.
6. Andreasen, N. C., Carpenter, W. T., Jr., Kane, J. M., Lasser, R. A., Marder, S. R., & Weinberger, D. R. (2005). Remission in schizophrenia: Proposed criteria and rationale for consensus. American Journal of Psychiatry, 162, 441-449.
7. Birchwood, M., Smith, J., Macmillan, F., Hogg, B., Prasad, R., Harvey, C., & Bering, S. (1989). Predicting relapse in schizophrenia: The development of an early signs monitoring system using patients and families as observers, a preliminary investigation. Psychological Medicine, 19, 649-656.
8. Bola, J. R., & Mosher, L. R. (2002). At issue: Predicting drug-free treatment response in acute psychosis from the Soteria project. Schizophrenia Bulletin, 28, 559-575.
9. Buchanan, R. W., & Carpenter, W. T. (1996). Targeted maintenance treatment in schizophrenia - Issues and recommendations. CNS Drugs, 5, 240-245.
10. Carpenter, W. T., Jr., Appelbaum, P. S., & Levine, R. J. (2003). The Declaration of Helsinki and clinical trials: A focus on placebo-controlled trials in schizophrenia. American Journal of Psychiatry, 160, 356-362.
11. Crow, T. J., Macmillan, J. F., Johnstone, A. L., & Johnstone, E. C. (1986). The Northwick Park study of first episodes of schizophrenia II. A randomized controlled trial of prophylactic neuroleptic treatment. British Journal of Psychiatry, 148, 120-127.
12. Early Psychosis Prevention and Intervention Centre. (2001). Case management in early psychosis: A handbook. Parkville, Victoria, Australia.
13. Edwards, J., Harris, M., & Herman, A. (2002). The early psychosis prevention and intervention centre, Melbourne, Australia: An overview, November 2001. In C. Ogura (Ed.), Recent advances in early intervention and prevention in psychiatric disorders (pp. 26-33), Tokyo: Seiwa Shoten.
14. Edwards, J., Elkins, K., Hinton, M., Harrigan, S. M., Donovan, K., Athanasopoulos, O., & McGorry, P. D. (2006). Randomized controlled trial of a cannabis-focused intervention for young people with first-episode psychosis. Acta Psychiatrica Scandinavica, 114, 109-117.
15. Edwards, J., & McGorry, P. D. (2002). Implementing early intervention in psychosis: A guide to establishing early psychosis services. London: Martin Dunitz.
16. Falloon, I. R. (1988). Handbook of behavioral family therapy. New York: Guilford Press.
17. Fenton, W. S., Mosher, L. R., Herrell, J. M., & Blyler, C. R. (1998). Randomized trial of general hospital and residential alternative care for patients with severe and persistent mental illness. American Journal of Psychiatry, 155, 516-522.
18. First, M. B., Spitzer, R. L., Williams, J. B. W., & Gibbon, M. (1997). Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II) user's guide and interview. Washington, DC: American Psychiatric Press.
19. Fitzgerald, P. B., Williams, C. L., Corteling, N., Filia, S. L., Brewer, K., Adams, A., de Castella, A. R. A., Rolfe, T., Davey, P., & Kulkarni, J. (2001). Subject and observer-rated quality of life in schizophrenia. Acta Psychiatrica Scandinavica, 103, 387-392.
20. Gilbert, M., Miller, K., Berk, L., Ho, V., & Castle, D. (2003). Scope for psychosocial treatments in psychosis: An overview of collaborative therapy. Australasian Psychiatry, 11, 220-224.
21. Gilbert, P. L., Harris, M. J., McAdams, L., & Jeste, D. V. (1995). Neuroleptic withdrawal in schizophrenic patients: A review of the literature. Archives of General Psychiatry, 52, 173-188.
22. Gitlin, M., Nuechterlein, K., Subotnik, K. L., Ventura, J., Mintz, J., Fogelson, D. L., Bartzokis, G., & Aravagiri, M. (2001). Clinical outcome following neuroleptic discontinuation in patients with remitted recent-onset schizophrenia. American Journal of Psychiatry, 158, 1835-1842.
23. Gleeson, J. F. (2004). The first psychotic relapse: Understanding the risks and the opportunities for prevention. In J. F. Gleeson, & P. D. McGorry (Eds.), Psychological interventions in early psychosis: A treatment handbook (pp. 157-174), Chichester: Wiley.
24. Goldberg, D. P. (1972). The detection of psychiatric illness by questionnaire: A technique for the identification and assessment of non-psychotic psychiatric illness. Maudsley Monograph, London: Oxford University Press.
25. Goldman, H. H., Skodol, A. E., & Lave, T. R. (1992). Revising Axis-V for DSM-IV - a review of measures of social functioning. American Journal of Psychiatry, 149, 1148-1156.
26. Gumley, A., O'Grady, M., McNay, L., Reilly, J., Power, K., & Norrie, J. (2003). Early intervention for relapse in schizophrenia: Results of a 12-month randomized controlled trial of cognitive behavioural therapy. Psychological Medicine, 33, 419-431.
27. Gupta, R. K., Chavan, B. S., & Kulhara, P. (1988). Psychosis NOS: A retrospective study. Indian Journal of Psychological Medicine, 11, 113-118.
28. Hilsenroth, M. J., Ackerman, S. J., Blagys, M. D., Baumann, B. D., Baity, M. R., Smith, S. R., Price, J. L., Smith, C. L., Heindselman, T. L., Mount, M. K., & Holdwick, D. J. (2000). Reliability and validity of DSM-IV axis V. American Journal of Psychiatry, 157, 1858-1863.
29. Hogarty, G. E. (2002). Personal therapy for schizophrenia and related disorders: A guide to individualized treatment. New York: Guilford Press.
30. Jackson, H., McGorry, P., Edwards, J., Hulbert, C., Henry, L., Francey, S., Maude, D., Cocks, J., Power, P., Harrigan, S., & Dudgeon, P. (1998). Cognitively-oriented psychotherapy for early psychosis (COPE): Preliminary results. British Journal of Psychiatry, 172(Suppl. 33), 93-100.
31. Jackson, H., McGorry, P., Henry, L., Edwards, J., Hulbert, C., Harrigan, S., et al. (2001). Cognitively oriented psychotherapy for early psychosis (COPE): A 1-year follow-up. British Journal of Clinical Psychology, 40, 57-70.
32. Kane, J. M., Rifkin, A., Quitkin, F., Nayak, D., & Ramos-Lorenzi, J. (1982). Fluphenazine vs placebo in patients with remitted, acute first-episode schizophrenia. Archives of General Psychiatry, 39, 70-73.
33. Lehman, A. F., Kreyenbuhl, J., Buchanan, R. W., Dickerson, F. B., Dixon, L. B., Goldberg, R., Green-Paden, L. D., Tenhula, W. N., Boerescu, D., Tek, C., Sandson, N., & Steinwachs, D. M. (2004). The Schizophrenia Patient Outcomes Research Team (PORT): Updated Treatment Recommendations 2003. Schizophrenia Bulletin, 30, 193-217.
34. Lehtinen, V., Aaltonen, J., Koffert, T., Räkköläinen, V., & Syvälahti, E. (2000). Two-year outcome in first-episode psychosis treated according to an integrated model. Is immediate neuroleptisation always needed? European Psychiatry, 15, 312-320.
35. Leucht, S., Barnes, T. R. E., Kissling, W., Engel, R. R., Correll, C., & Kane, J. M. (2003). Relapse prevention in schizophrenia with new-generation antipsychotics: A systematic review and exploratory meta-analysis of randomized, controlled trials. American Journal of Psychiatry, 160, 1209-1222.
36. Lieberman, J. A., Jody, D., & Geisler, S. (1993). Time course and biological correlates of treatment response in first-episode schizophrenia. Journal of Clinical Psychiatry, 57, 5-9.
37. Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., Severe, J., & Hsiao, J. K. (2005). Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New England Journal of Medicine, 353, 1209-1223.
38. Linszen, D. H., Dingemans, P., Van Der Does, J. W., Nugter, A., Scholte, P., Lenior, R., & Goldstein, M. J. (1996). Treatment, expressed emotion and relapse in recent onset schizophrenic disorders. Psychological Medicine, 26, 333-342.
39. Linszen, D. H., Wouters, L., Dingemans, P., de Haan, L., & Nieman, D. (2004). Early and 3-year sustained intervention in first episode schizophrenia: Relapse, stabilization and its predictors [Abstract]. Schizophrenia Research, 67(Suppl. 1), 18.
40. Lukoff, D., Liberman, R. P., & Nuechterlein, K. H. (1986). Symptom monitoring in the rehabilitation of schizophrenic patients. Schizophrenia Bulletin, 12, 578-593.
41. Marwaha, S., & Johnson, S. (2004). Schizophrenia and employment: A review. Social Psychiatry and Psychiatric Epidemiology, 39, 337-349.
42. McFarlane, W. R., Dixon, L., Lukens, E., & Lucksted, A. (2003). Family psychoeducation and schizophrenia: A review of the literature. Journal of Marital & Family Therapy, 29, 223-245.
43. McGorry, P. (2005). Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders. Australian and New Zealand Journal of Psychiatry, 39, 1-30.
44. McGorry, P. D., Edwards, J., Mihalopoulos, C., Harrigan, S. M., & Jackson, H. J. (1996). EPPIC: An evolving system of early detection and optimal management. Schizophrenia Bulletin, 22, 305-326.
45. Montgomery, S. M. (1979). Depressive symptoms in acute schizophrenia. Progress in Neuro-Psychopharmacology, 3, 429-433.
46. Mueser, K. T., & Glynn, S. M. (1999). Behavioral family therapy for psychiatric disorders, 2nd ed. Oakland, CA: New Harbinger.
47. Müller, N. (2004). Mechanisms of rrelapse prevention in schizophrenia. Pharmacopsychiatry, 37(Suppl. l2), S141-S147.
48. National Early Psychosis Project Clinical Guidelines Working Party. (1998). Australian clinical guidelines for early psychosis. Melbourne: National Early Psychosis Project, University of Melbourne.
49. Nuechterlein, K. H., Dawson, M. E., Gitlin,M., Ventura, J., Goldstein, M. J., Snyder, K. S., Yee, C. M., & Mintz, J. (1992). Developmental processes in schizophrenic disorders: Longitudinal studies of vulnerability and stress. Schizophrenia Bulletin, 18, 387-424.
50. Overall, J. E., & Gorham, D. R. (1962). The Brief Psychiatric Rating Scale. Psychiatric Reports, 10, 799-812.
51. Perepletchikova, F., & Kazdin, A. E. (2005). Treatment integrity and therapeutic change: Issues and research recommendations. Clinical Psychology: Science and Practice, 12, 365-383.
52. Pourmand, D., Kavanagh, D. J., & Vaughan, K. (2005). Expressed emotion as predictor of relapse in patients with comorbid psychoses and substance use disorder. Australian and New Zealand Journal of Psychiatry, 39, 473-478.
53. Pilling, S., Bebbington, P., Kuipers, E., Garety, P., Geddes, J., Orbach, G., & Morgan, C. (2002). Psychological treatments in schizophrenia: I. Meta-analysis of family intervention and cognitive behaviour therapy. Psychological Medicine, 32, 763-782.
54. Power, P., Iacoponi, E., Russell, M., Fisher, H., McGuire, P., Garety, P., Valmaggio, L., & Craig, T. (2004). A randomised controlled trial of an early detection team in first-episode psychosis: Provisional findings of the LEO CAT study. Schizophrenia Research, 70, 131-131.
55. Robinson, D. G., Woerner, M. G., Alvir, J. M. J., Bilder, R., Goldman, R., Geisler, S., Koreen, A., Sheitman, B., Chakos, M., Mayerhoff, D., & Lieberman, J. A. (1999). Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Archives of General Psychiatry, 56, 241-247.
56. Ryle, A., & Kerr, I. B. (2002). Introducing cognitive analytic therapy: Principles and practice. Chichester: Wiley.
57. Schooler, N., Rabinowitz, J., Davidson, M., Emsley, R., Harvey, P. D., Kopala, L., McGorry, P. D., Van Hove, I., Eerdekens, M., Swyzen, W., & De Smedt, G. (2005). Risperidone and haloperidol in first-episode psychosis: A long-term randomized trial. American Journal of Psychiatry, 162, 947-953.
58. Szmukler, G. I., Burgess, P., Herrman, H., & Benson, A. (1996). Caring for relatives with serious mental illness: The development of Experience of Caregiving Inventory. Social Psychiatry & Psychiatric Epidemiology, 31, 137-148.
59. Ventura, J., Liberman, R. P., Green, M. F., Shaner, A., & Mintz, J. (1998). Training and quality assurance with the Structured Clinical Interview for DSM-IV (SCID-I/P). Psychiatry Research, 79, 163-173.
60. Wade, D., Harrigan, S., Edwards, J., Burgess, P. M., Whelan, G., & McGorry, P. D. (2005). Patterns and predictors of substance use disorders and daily tobacco use in first-episode psychosis. Australian and New Zealand Journal of Psychiatry, 39, 892-898.
61. Wiedemann, G., Rayki, O., Feinstein, E., & Hahlweg, K. (2002). The Family Questionnaire: Development and validation of a new self-report scale for assessing expressed emotion. Psychiatry Research, 109, 265-280.
62. Wiersma, D., Nienhuis, F. J., Sloof, C. J., & Giel, R. (1998). Natural course of schizophrenic disorders: A 15-year follow-up of a Dutch incidence cohort. Schizophrenia Bulletin, 24, 75-85.
63. Zhang, M., Wang, M., Li, J., & Phillips, M. R. (1994). Randomised-control trial of family intervention for 78 first-episode male schizophrenic patients: An 18-month study in Suzhou, Jiangsu. British Journal of Psychiatry, 165(Suppl. 24), 96-102.
64. Zimmerman, M., Posternak, M. A., & Chelminski, L. (2004). Derivation of a definition of remission on the Montgomery-Asberg Depression Rating Scale corresponding to the definition of remission on the Hamilton Rating Scale for Depression. Journal of Psychiatric Research, 38, 577-582.